CV Lattes
ResearcherID
ORCID
Google Scholar Citations
Hospital das Clínicas da Faculdade de Medicina da USP (HCFMUSP). Instituto de Psiquiatria Doutor Antonio Carlos Pacheco e Silva (IPq) (Institutional affiliation from the last research proposal) Birthplace: Brazil
bachelor's at Medicina from Faculdade de Medicina do ABC (1975) and doctorate at Psiquiatria from Ruprecht-Karls Universität Heidelberg (1979). Has experience in Medicine, acting on the following subjects: esquizofrenia, schizophrenia, endógenas, interleukin-2 and interferon-y. (Source: Lattes Curriculum)
| Articles published in Pesquisa FAPESP Magazine about the researcher: |
| Falta de armonía celular |
| Cellular disharmony |
| A jigsaw puzzle in construction |
| More itemsLess items |
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
As in other areas of knowledge, there has been an intense degree of informatization of the scientific activities applied to Psychiatry, Psychology and Neurosciences, in parallel to the rapid growth of clinical and neurobiological databases of research. As expected, this growing wave of informatization has been brought to the Institute of Psychiatry (IPq), one of the six Institutes of Clin…
The search for the biological substrate of neuropsychiatric diseases is a pre-requisite for the development of more efficient therapies and, most importantly, preventive strategies by means of early diagnosis. The experimental attempts to identify specific markers for the different diseases remain unsuccessful. At least partially, these negative results derive from a probable lack of spec…
The search for the biological substrate of neuropsychiatric diseases is a pre-requisite for the development of more efficient therapies and, most importantly, preventive strategies by means of early diagnosis. The experimental attempts to identify specific markers for the different diseases remain unsuccessful. At least partially, these negative results derive from a probable lack of spec…
(Only some records are available in English at this moment)
In view of the socio-demographic challenges imposed and the high functional impact of Alzheimer's disease (AD), it is important to carry out studies that aim to uncover the pathophysiological mechanisms underlying this disease. Such understanding will broaden the spectrum of substrates with potential use as biomarkers, thus contributing to early diagnoses, as well to discover pathological…
Schizophrenia is a psychiatric disease that affects around 1% of the world's population, and comprises a number of heterogeneous symptoms complicating treatment. Above all, several environmental and genetic factors influence its etiology and, therefore, diagnosing the disease before it manifests itself is a further step towards treatment, characterizing this group in UHR (ultra high risk)…
Psychotic disorders are frequent conditions that affect around 3.5% of the general population. Schizophrenia (SCZ) - the most frequent psychotic disorder - affects about 1% of the population, tends to be chronic and disabling. Even before presenting psychosis sympthoms, patients present behavioral changes that allow to follow and track these individuals. Based on some clinical and demogra…
(Only some records are available in English at this moment)
Schizophrenia is a complex psychiatric disorder that affects about 1% of the world's population. Despite considerable progress in recent years, the etiology of the disease has not yet been clarified. The beginning and the progression of the disease are heterogeneous and often the patients' symptoms are common to other neuropsychiatric disorders, making differentiation and diagnosis throug…